Navigation Links
China Yingxia International Announces Soybean Milk Production Lines Acquisition
Date:3/28/2008

NEW YORK, March 28 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI), (the "Company") a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplements, and personal care products in China, today announced that it is in the final stages of the acquisition of six soybean milk production lines from King International Food Corporation Limited ("King"), a Sino-Australian joint venture.

The Company has spent over $4 million dollars to acquire production equipment, technical know-how, and marketing resources from King. The Company is now in the process of engaging a third party to provide an asset evaluation report to formally complete the purchase of the production lines. The Company expects the transaction to be completed before the end of the second quarter of 2008.

"We expect to begin production by the end of the second quarter after the acquisition formally closes," stated Ms. Yingxia Jiao, the Company's chairwoman. "This marks our first step toward becoming a major player in the soy milk business in China. We have other exciting projects in the pipeline for this year and I hope you can all join me for our fourth quarter and 2007 full year conference call next Monday."

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang in mainland China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, cactus-based herbal supplements, personal care products, Nestle products, and organic rice products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-lo
'/>"/>

SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cells from the Research Institute of the MUHC on the road to China
2. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
3. China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call
4. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
6. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
7. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
8. China Nepstar Chain Drugstore Announces Dividend
9. Alsius Corporation Receives Regulatory Approval in China and Mexico
10. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
11. China Nepstar Chain Drugstore Reports 231.5% Increase in Net Income and Record Gross Margin of 48.5% for Fourth Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ecent announcement, Governor,Schwarzenegger recom...,"luxury" items such as veterinary services, whic...overpopulation. Animal welfare advocates across t...ners to take action and contact the,governor and ...companion animals are family members and taking ca...
(Date:11/21/2008)... are not given adequate drug therapy. This is the ...dition of Deutsches rzteblatt International ( Dt...r et al. present the German results of this prospe... took part in the study. They enrolled 5594 patien... cardiovascular diseases and 10.8% only exhibited ...
(Date:11/21/2008)...ech Institute’s (CHI) flagship event, the Mo...009) will feature four of molecular medicine&rsquo... Needham, MA (PRWEB) November 21, ...;s (CHI) flagship event, the Molecular Medicine Tr...our of molecular medicine’s thought leaders ...
(Date:11/21/2008)...ories of living with HIV/AIDS , , WASHINGTO...leading cause of death for African American women ... by 30 percent per year if all HIV infected person...hanges to limit the spread of the disease. , ,...lt.org ) was featured this week at the 2008 Nation...
Breaking Medicine News(10 mins):Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 2Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 3Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 4Health News:Southern AIDS Living Quilt Raises Awareness at National HIV Summit 2
...nd Control (ECDC) based in Stockholm has proposed ...es with regard to the avian flu. //Approval has be...ssels. The guidelines are inclusive of controllin...l risk assessment. Contact with the birds that are...
...d flu, increasing the risk of human infection in p...from a 35-year-old man who died in Jakarta last mo...in a World Health Organization reference laborator... The report takes the number of confirmed human ca...
...lastic Syndrome (MDS), treated with 500 mcg of Ara...d to improve the hemoglobin content in 70% of pati...gen Biotech, which conducted a Phase II trial with...with 500 mcg of Aranesp every three weeks. MDS is ...
...drug that can take care of everything from Alzheim...that it can also induce cancer cells to commit sui...urgh report in the December 9 issue of the Journal...n can prove to be deadly for cancer cells in combi...
Other Medicine News:Health News:Indonesia Has Ninth Bird-Flu Death as Risk Mounts 2Health News:Aspirin induces Cancer Cells To Commit Suicide 2
(Date:11/12/2008)...12 A new study being,pu...ll help answer the,question, what causes Parkinson...n the medical research into,Parkinson,s disease is...ie,in the first place. Answering this question has...early identical types of brain cells that produce,...
(Date:11/12/2008)... and LOD, Israel, November 12 Surg..., NY indicated that,patient-specific CTA data can ...entor(TM), Simbionix US) with high face validity. ... improved the operative flow,increased patient sa...verall operative and fluoroscopy time and the amou...
(Date:11/12/2008)...en Label Study and New Data Suggesting Need for Im...08 Annual Meeting -, EXTON, Pa., Nov. 12 /PRNewsw... VPHM ) today announced the presentation of data ...n this study Cinryze(TM) C1 inhibitor,therapy succ...ioedema (HAE),attacks seen in the study through th...
(Date:11/12/2008)... The Miami Jewish Home and Hospital...inical Research today,announced that they are acti... Phase 3 clinical trial that is evaluating the saf...on as a treatment for mild-to-moderate,Alzheimer,s...zheimer,s Association, more than,5 million people ...
Breaking Medicine Technology:A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 1Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 3Study finds limiting work hours for surgical residents enhances training 1351 1Study finds limiting work hours for surgical residents enhances training 1351 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 1Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 3BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 1BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 2
...T, June 11, 2007 (MARKET WIRE via COMTEX News,Netw...arget=,"_blank" href="http://www.myriad.com/">www....athematical comparison of a,"Staggered Start" and ...th a "Natural History Staggered Start" clinical tr...on Conference held,June 9 - 12, 2007, in Washingto...
...INESS WIRE)--Jun 12, 2007 - Inspire,Pharmaceutical...ists and collaborators related to Inspire will pre...ean Academy of,Allergology and Clinical Immunology...weden and at the 30th European Cystic Fibrosis,Soc... in Belek,Turkey., The EAACI Congress includes tw...
Other Medicine Technology:Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3
An excellent preventative/thera-peutic device for wearing during sports or construction activity. Helps dampen vibration and shock often transmitted during periods of repetitive motion. Provides re
...controlling range of motion of the elbow., ,While...remity bracing solutions, in recent years an incre...custom and post-operative elbow stabilization brac...braces come in single hinge and dual hinge designs...
Premium Tennis Elbow Support is 2" wide with loop-lock contact closure and is foam-lined for comfort.
...Joint Technology" elbow brace has been designed by...h pain free range of motion. ,The SADER II Elbow/F...inician and patient with adjustable static and dyn... and Forearm Fractures, Post Surgical loss of Moti...
Medicine Products: